Status:
COMPLETED
The Use of D5LR Versus LR for Induction of Labor and Time to Delivery in Multiparous and Primiparous Patient's With Favorable and Unfavorable Bishop's Scores
Lead Sponsor:
Ascension Health
Conditions:
Induction of Labor Affected Fetus / Newborn
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
Currently, the optimum IV fluid for induction of labor is unknown. The goal of this study is to determine the optimum fluid for induction of labor, D5LR versus LR. The investigators hypothesize that p...
Detailed Description
Induction of labor is increasingly common in the United States, as the overall rate has increased from 9.5% in 1990 to 22.1% in 2006 with the goal to stimulate contractions prior to the onset of spont...
Eligibility Criteria
Inclusion
- Pregnant women, age 18 - 45, that were admitted for induction of labor without any co-morbid conditions and their respective newborns with
- Induction of labor
- Singleton pregnancies
- Vertex presentation
- Pregnancies at 39 0/7 weeks gestation - 41 6/7 weeks gestation
- All races/ethnicities
Exclusion
- Multifetal gestations
- Noncephalic presentation
- Preexisting medical conditions:
- Maternal cardiac disease
- Lung diseases
- Chronic hypertension
- Pregestational or gestational diabetes
- gHTN or Pre-Eclampsia
- medical indication for induction of labor (olighydramnios, IUGR)
Key Trial Info
Start Date :
March 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 19 2019
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT03822052
Start Date
March 15 2019
End Date
December 19 2019
Last Update
December 23 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ascension Genesys Hospital
Grand Blanc, Michigan, United States, 48439